|Articles|April 1, 2012
- BioPharm International-04-01-2012
- Volume 25
- Issue 4
BioPharm International, April 2012 Issue (PDF)
Optimizing Filtration Strategies
Advertisement
Articles in this issue
almost 14 years ago
A Strong Start to 2012almost 14 years ago
Pointed Debatealmost 14 years ago
Optimizing Adjuvant Filtrationalmost 14 years ago
Preparing for an FDA Inspection in a Global Pharmaceutical Environmentalmost 14 years ago
The Growing Orphan-Drug Paradigmalmost 14 years ago
Manufacturers Wrestle with Drug Abuse and Critical Shortagesalmost 14 years ago
Small Changes, System-Wide Impactalmost 14 years ago
Knowledge Management Implementationalmost 14 years ago
Ways to Recover Lost Marginsalmost 14 years ago
Single-Use Redundant FiltrationNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
GSK’s Arexvy Gains EU Approval for Adults Aged 18 Years and Older
2
HanchorBio–WuXi Biologics Partnership Targets Fusion Protein Development Challenges
3
Optimizing Kinetics Assays to Avoid Avidity Effects
4
Industry Outlook 2026: Biopharma Industry Confronts Skills Shortage with Strategic Automation (Part 2)
5
